Keymed Biosciences, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG5252B1023
HKD
71.35
4.35 (6.49%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
The United Laboratories International Holdings Ltd.
China Medical System Holdings Ltd.
Grand Pharmaceutical Group Ltd.
Simcere Pharmaceutical Group Ltd.
Sinopharm Group Co., Ltd.
China Resources Pharmaceutical Group Ltd.
Hygeia Healthcare Holdings Co., Ltd.
China Traditional Chinese Medicine Holdings Co. Ltd.
HUTCHMED (China) Ltd.
Akeso, Inc.
Keymed Biosciences, Inc.

Why is Keymed Biosciences, Inc. ?

1
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 0%
  • Poor long term growth as Operating profit has grown by an annual rate -5.18% of over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -39.11
2
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 48.34%, its profits have risen by 65.8%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Keymed Biosciences, Inc. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Keymed Biosciences, Inc.
48.34%
1.97
58.94%
Hang Seng Hong Kong
8.25%
0.41
19.93%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
453.98%
EBIT Growth (5y)
-5.18%
EBIT to Interest (avg)
-39.11
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.57
Sales to Capital Employed (avg)
0.09
Tax Ratio
1.24%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
5.53
EV to EBIT
-46.02
EV to EBITDA
-63.59
EV to Capital Employed
12.50
EV to Sales
18.30
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-27.17%
ROE (Latest)
-7.87%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

12What is working for the Company
NET SALES(Q)

Highest at HKD 535.73 MM

PRE-TAX PROFIT(Q)

At HKD -80.91 MM has Grown at 77.47%

NET PROFIT(Q)

At HKD -84.94 MM has Grown at 76.9%

-2What is not working for the Company
NO KEY NEGATIVE TRIGGERS

Here's what is working for Keymed Biosciences, Inc.

Net Sales
At HKD 535.73 MM has Grown at 804.12%
Year on Year (YoY)
MOJO Watch
Near term sales trend is extremely positive

Net Sales (HKD MM)

Net Sales
Highest at HKD 535.73 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (HKD MM)

Pre-Tax Profit
At HKD -80.91 MM has Grown at 77.47%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (HKD MM)

Net Profit
At HKD -84.94 MM has Grown at 76.9%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is positive

Net Profit (HKD MM)

Depreciation
Highest at HKD 52.51 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (HKD MM)